BioCentury
ARTICLE | Company News

Oclassen Pharmaceuticals Inc. deal

January 16, 1995 8:00 AM UTC

Bock Pharmacal Co.'s 240-person sales force will handle all promotional activities for Oclassen’s Condylox (podofilox) genital wart solution to obstetricians, gynecologists, primary care physicians and public health clinics. Oclassen (San Rafael, Calif.) will continue to promote the 0.5 percent topical solution to dermatologists and urologists.

Oclassen also acquired from Johns Hopkins Hospital exclusive worldwide rights to patents covering the use of topical aminopenicillin products to treat acne. Aminopenicillins are relatively fat soluble which may lead to enhanced skin penetration. ...